Research map: Characteristics of fusion genes in breast cancer

Back to the article

Papers in this map

  1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries · Freddie Bray · 2024 · 26051 citations · Cited by this paper
  2. Limb-bud and heart (LBH) promotes expansion and survival of esophageal adenocarcinoma cells · 2026 · Related
  3. Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children · Alexander Edward Dela Cruz Drilon · 2018 · 2832 citations · Cited by this paper
  4. Novel role of the class II α-isoform of phosphatidylinositol 3-kinase in hepatocellular carcinoma: suppressing metastasis by targeting Wnt/β-catenin signaling via inhibiting phosphorylation of LRP6 · 2026 · Related
  5. NTRK fusion-positive cancers and TRK inhibitor therapy · Emiliano Cocco · 2018 · 1508 citations · Cited by this paper
  6. M196R-TNFR2 and membrane TNFα down-regulate soluble TNFα-induced pro-metastatic functions in triple-negative breast cancer cells · 2026 · Related
  7. Sequence analysis of mutations and translocations across breast cancer subtypes · Shantanu Otto Banerji · 2012 · 1209 citations · Cited by this paper
  8. APLP2 as a molecular link between immune regulation and bone metabolism in hepatocellular carcinoma: evidence from scRNA-seq and functional validation · 2026 · Related
  9. Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies · Yi‐Zhou Jiang · 2019 · 1139 citations · Cited by this paper
  10. Sphingolipid metabolic subtyping defines SPHK1 as an oncogene and characterizes immunosuppressive TME features in gastric cancer · 2026 · Related
  11. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials · David S. Hong · 2020 · 1027 citations · Cited by this paper
  12. TMEM33 regulates the proliferation and migration of lung adenocarcinoma by promoting the PI3K/AKT/mTOR signaling pathway · 2026 · Related
  13. Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomas · David Jones · 2008 · 958 citations · Cited by this paper
  14. Integrative analysis of SLFN11-related DEGs reveals novel biomarkers for cisplatin sensitivity and immune modulation in colorectal cancer · 2026 · Related
  15. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma · Cristina E. Tognon · 2002 · 919 citations · Cited by this paper
  16. Immunotherapy resistance in colorectal cancer: therapeutic strategies and biomarker-guided approaches · 2026 · Related
  17. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck · Marta Persson · 2009 · 794 citations · Cited by this paper
  18. The Wnt signaling networks in higher-grade meningiomas: from molecular pathogenesis to therapeutic innovation · 2026 · Related
  19. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers · Qingsong Gao · 2018 · 664 citations · Cited by this paper
  20. Resolving intra-tumor heterogeneity and clonal evolution of core-binding factor acute myeloid leukemia patients with single-cell resolution · 2025 · Related
  21. Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts · Shunqiang Li · 2013 · 632 citations · Cited by this paper
  22. Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma · Lipika Goyal · 2016 · 565 citations · Cited by this paper
  23. Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer · Chao Dong · 2021 · 385 citations · Cited by this paper
  24. A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells · Hui Li · 2008 · 326 citations · Cited by this paper
  25. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma · Yotam Drier · 2016 · 303 citations · Cited by this paper
  26. Triple-negative breast cancer: promising prognostic biomarkers currently in development · Jasmine Singh Sukumar · 2020 · 243 citations · Cited by this paper
  27. Targeted protein degradation for cancer therapy · Matthias Hinterndorfer · 2025 · 196 citations · Cited by this paper
  28. Recurrent read-through fusion transcripts in breast cancer · Katherine Elena Varley · 2014 · 192 citations · Cited by this paper
  29. ETV6–NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages · Chris L. Lannon · 2005 · 166 citations · Cited by this paper
  30. Detection of ALK Gene Rearrangement in Non-small Cell Lung Cancer: A Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization with Correlation of ALK Protein Expression · Hyojin Kim · 2011 · 164 citations · Cited by this paper
  31. FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data · Andrea Sboner · 2010 · 161 citations · Cited by this paper
  32. Recurrent ESR1–CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers · Jamunarani Veeraraghavan · 2014 · 158 citations · Cited by this paper
  33. Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers · Tingting Jiang · 2020 · 150 citations · Cited by this paper
  34. Adenoid cystic carcinomas of the breast and salivary glands (or ‘The strange case of Dr Jekyll and Mr Hyde’ of exocrine gland carcinomas) · Caterina Marchiò · 2010 · 147 citations · Cited by this paper
  35. The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas · Steven G. DuBois · 2018 · 137 citations · Cited by this paper
  36. Relapsed Classic E-Cadherin ( CDH1 )–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 ( ERBB2 ) Gene Mutations · Jeffrey S. Ross · 2013 · 136 citations · Cited by this paper
  37. INTEGRATE: gene fusion discovery using whole genome and transcriptome data · Jin Zhang · 2015 · 136 citations · Cited by this paper
  38. RET rearrangements are actionable alterations in breast cancer · Bhavna Paratala · 2018 · 128 citations · Cited by this paper
  39. CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data · Liqing Tian · 2020 · 125 citations · Cited by this paper

Source: OpenAlex (CC0)